Member Info for KUMS

could be sitting on large amount of GAS like it's neighbour!

In at 0.38p on TW recommendation,, sold @ 1.40p & back in at .60p Needed patience for making money. Same again now!

Just got tipped by TW.

You can follow Sosandar on twitter! GAME ON!

About Sosander Launched by award winning media duo, Ali Hall and Julie Lavington, in September 2016, Sosandar is an e-commerce, womenswear brand targeted at 35-55-year-old women, who have graduated from younger brands like Topshop and ASOS and are frustrated by the 'frumpy', old fashioned offering of certain established brands. Sosandar offers this under-served audience a fashionable and affordable range of clothing, with a premium aesthetic, supported by daily editorial content providing fashion inspiration and advice. Sosandar has already received coverage in major national newspapers and magazines, from Sunday Times Style to Evening Standard, and Marie Claire to Cosmopolitan. It has also been featured on TV and has celebrity endorsement; including dressing the panel and guests on ITV's biggest daytime show, Loose Women.

Disappointment! Time will tell!

When they come they come in 2s'! LOL!

Loan to Thread 35 Limited and temporary suspension Heads of terms agreed for acquisition Potential reverse transaction of e-commerce womenswear brand Orogen plc (AIM: ORO), the recently formed AIM Rule 15 cash shell seeking a reverse takeover candidate, announces it has agreed heads of terms with Thread 35 Limited ("Thread") to acquire Thread's entire issued share capital, subject to certain conditions and due diligence. This acquisition would constitute a reverse transaction under the AIM Rules. Thread operates an e-commerce womenswear brand, targeting 35-55-year-old women under the brand name "Sosandar". As part of the proposed transaction Orogen has made a secured loan of up to £250,000 ("Loan") to Thread. The Loan is interest free and may be drawn down in two tranches. The first tranche of £100,000 may be drawn down immediately, whilst the second tranche may only be drawn down on the condition that letters of intent are obtained by the Company from Thread's shareholders to accept the terms of an offer to acquire their shares. Temporary suspension Consequently, the Company has requested that trading in its shares is temporarily suspended, pending either the publication of an admission document or until the proposed acquisition negotiations are terminated. Adam Reynolds, Chairman of Orogen, commented: "I am delighted that Orogen has found an attractive acquisition opportunity so quickly. Sosandar is operating in a market that is showing significant growth and it has a highly motivated and experienced management team. With added balance sheet strength I believe we will be able to accelerate this growth opportunity, benefiting all shareholders in the enlarged group."

All approved!

paid.

taking advantage during stock transfer etc we see recently and topping up. No brainer at this level.

of 10.5m EUR already! RNS: Amryt, the pharmaceutical company focused on best-in-class treatments for rare and orphan diseases, will hold its Annual General Meeting this morning and Chairman, Harry Stratford, will make the following comment on current trading: "The Group has made substantial progress since its admission to trading on AIM in April 2016 and this has continued in the new financial year. "As previously reported on 30 March 2017, sales of Lojuxta are expected to generate revenues of EUR 10.5m on an annualised basis and management is encouraged by 'real-world' data results* as it seeks to increase sales of this cholesterol-lowering agent in the treatment of the Homozygous Familial Hypercholesterolaemia ("HoFH") across its licenced territories. "The pivotal Phase 3 trial, "EASE", which is evaluating AP101, the Company's lead development asset, as a potential treatment for Epidermolysis Bullosa ("EB"), the distressing skin disorder, enrolled its first patient in April and the trial remains on track to be one of the largest studies of its kind in this rare disease. "The Board continues to view prospects very positively."

Hi EB!

target is 88p Stifel's target 60p!

paid.

That was the bottom we saw & now move upwards! Well done to those who took advantage!!

just went thro! NT to buy so mms short of shares!

Thanks

today!

& buys @ 2.40p